Shield Therapeutics plc (STX) — Cash Flow Reinvestment Rate
Latest as of June 2020:
0.00x
Shield Therapeutics plc (STX) has a Cash Flow Reinvestment Rate of 0.00x as of June 2020, reinvesting GBX2.00K (capex GBX2.00K ) from operating cash flow of GBX2.40 Million. Check Shield Therapeutics plc (STX) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
GBX2.00K
Capex + Investments
Operating Cash Flow
GBX2.40 Million
GBX
Capital Expenditures
GBX2.00K
GBX
Annual Cash Flow Reinvestment Rate for Shield Therapeutics plc (None–None)
Year-by-year capital reinvestment analysis for Shield Therapeutics plc. For live market cap and broader valuation context, see Shield Therapeutics plc (STX) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (GBX) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow